Literature DB >> 10502399

Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.

Y Y Mo1, W T Beck.   

Abstract

DNA topoisomerase (topo) II is an essential nuclear enzyme that plays an important role in DNA metabolism and chromosome organization. In the present study, we expressed human topo IIalpha in mammalian cells by fusion to an enhanced green fluorescent protein (EGFP). Decatenation assays indicated that the EGFP-topo IIalpha is catalytically active in vitro. Assays for band depletion, growth inhibition, and cytotoxicity by topo II inhibitors suggested that the fusion protein is also functional in vivo. By following its subcellular localization throughout the cell cycle in living cells, we found that the fusion protein is localized to the nucleus and nucleolus at interphase, and it is bound to chromosomal DNA at every stage of mitosis. Of importance, a mutant EGFP-topo IIalpha, in which the active Tyr 805 is replaced by Phe (Y805F) and is catalytically inactive, still binds to chromosomal DNA throughout the cell cycle like the wild-type enzyme. Together, our results suggest that the ability of topo IIalpha to bind to chromosomal DNA in the cell, a presumed requirement for its structural role, can be separated from its catalytic activity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502399     DOI: 10.1006/excr.1999.4616

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

Review 1.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  Identification of nuclear phosphatidylinositol 4,5-bisphosphate-interacting proteins by neomycin extraction.

Authors:  Aurélia E Lewis; Lilly Sommer; Magnus Ø Arntzen; Yvan Strahm; Nicholas A Morrice; Nullin Divecha; Clive S D'Santos
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

3.  Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

Authors:  S Zhu; M Sachdeva; F Wu; Z Lu; Y-Y Mo
Journal:  Oncogene       Date:  2009-12-21       Impact factor: 9.867

4.  TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway.

Authors:  Jinxin Liu; Yizhi Chen; Shuai Shuai; Dapeng Ding; Rong Li; Rongcheng Luo
Journal:  Tumour Biol       Date:  2014-06-06

5.  Human OGG1 undergoes serine phosphorylation and associates with the nuclear matrix and mitotic chromatin in vivo.

Authors:  Françoise Dantzer; Luisa Luna; Magnar Bjørås; Erling Seeberg
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

6.  Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis.

Authors:  Marta Agostinho; José Rino; José Braga; Fernando Ferreira; Soren Steffensen; João Ferreira
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

7.  The dynamics of DNA topoisomerase IIalpha in living cells.

Authors:  John R Daum; Yin Yuan Mo; Gary J Gorbsky
Journal:  Methods Mol Biol       Date:  2009

8.  MicroRNA-mediated regulation of Ubc9 expression in cancer cells.

Authors:  Fangting Wu; Shuomin Zhu; Yanna Ding; William T Beck; Yin-Yuan Mo
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

9.  Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.

Authors:  Xinsheng Peng; Wei Guo; Tiejian Liu; Xi Wang; Xiang'an Tu; Dafu Xiong; Song Chen; Yingrong Lai; Hong Du; Guangfu Chen; Guanglin Liu; Yubo Tang; Shuai Huang; Xuenong Zou
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

10.  Suppression of cell growth and invasion by miR-205 in breast cancer.

Authors:  Hailong Wu; Shoumin Zhu; Yin-Yuan Mo
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.